Isolated Chromosome 6q27 Terminal Deletion Syndrome.

Cureus

Vascular and Endovascular Surgery, Western Vascular Institute, Galway, IRL.

Published: May 2020

Any change in either the short (p) or long (q) arm of chromosome six can result in a variety of disorders.  A two-year-old female child came to us with a history of sudden onset generalized tonic-clonic seizure. She had a syndromic face with frontal bossing and palpable thinning of the right lower lip and an apparent facial asymmetry while crying due to the hypoplasia of the right depressor angularis oris. Her joints were hypermobile and hypotonic. Chromosomal karyotyping exhibited a normal female karyotype, but pathogenic microarray genetic evaluation showed a loss of approximately 783 kb of the 6q27 terminus. She was diagnosed with chromosome 6q27 terminal deletion and managed with anti-seizure medications.  Chromosome 6q27 terminal deletion can present with an array of structural and developmental anomalies. It is, therefore, necessary to understand the typical phenotypic and distinctive clinical features of congenital chromosome 6q27 terminal deletion syndrome for early diagnosis and intervention.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292719PMC
http://dx.doi.org/10.7759/cureus.8103DOI Listing

Publication Analysis

Top Keywords

chromosome 6q27
16
6q27 terminal
16
terminal deletion
16
deletion syndrome
8
6q27
5
isolated chromosome
4
terminal
4
deletion
4
syndrome change
4
change short
4

Similar Publications

Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangement.

Drug Resist Updat

January 2025

Loma Linda University Cancer Center, Loma Linda, CA 92354, United States; Department of Basic Sciences, Loma Linda University, Loma Linda, CA 92354, United States. Electronic address:

Chromosomal rearrangements (CR) initiate leukemogenesis in approximately 50 % of acute myeloid leukemia (AML) patients; however, limited targeted therapies exist due to a lack of accurate molecular and genetic biomarkers of refractory mechanisms during treatment. Here, we investigated the pathological landscape of treatment resistance and relapse in 16 CR-AML patients by monitoring cytogenetic, RNAseq, and genome-wide changes among newly diagnosed, refractory, and relapsed AML. First, in FISH-diagnosed KMT2A (MLL gene, 11q23)/AFDN (AF6, 6q27)-rearrangement, RNA-sequencing identified an unknown CCDC32 (15q15.

View Article and Find Full Text PDF

Genomic profiles and clinical presentation of chordoma.

Acta Neuropathol Commun

August 2024

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Article Synopsis
  • Chordoma is a rare bone cancer affecting mainly adults, with an average diagnosis age of 45.5 years; it is most commonly found in the clivus, spinal column, and sacrum.
  • A large majority of patients (97.5%) underwent surgery, and many also received supplementary treatments; however, no significant cancer types appeared frequently among patients' families aside from the most common cancers.
  • Genomic analysis of tumor samples revealed recurrent mutations, notably in PIK3CA, and differences in genetic alterations based on the tumor location, indicating a complex relationship between tumor genetics and clinical outcomes.
View Article and Find Full Text PDF

Generation of two isogenic patient-derived human-induced pluripotent stem cell clones with 6q27 deletion.

Stem Cell Res

October 2024

Developmental Origins of Pediatric Cancer Junior Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany. Electronic address:

We generated two human induced pluripotent cell (hiPSC) isogenic clones from an 11-year-old patient with 6q27 deletion syndrome. The heterozygous deletion encompasses approximately 240 kilobases, affecting 6 genes (promoter region of WDR27, coding regions of C6orf120, PHF10, DYNLT2, ERMARD, LINC00242). The patient suffered from epilepsy, psychosocial retardation, and a metabolic disorder.

View Article and Find Full Text PDF
Article Synopsis
  • Maternal uniparental disomy for chromosome 6 (upd) is linked to intrauterine growth restriction (IUGR), but the exact clinical details are not well defined.
  • Two new cases were analyzed, one showing mixed isodisomy and heterodisomy patterns, and the other having a homozygous mutation in SCUBE3 along with maternal upd.
  • Of the 21 documented cases of maternal upd, 85.7% experienced IUGR, highlighting a significant correlation between this genetic condition and growth issues in utero.
View Article and Find Full Text PDF

Novel liquid biopsy CNV biomarkers in malignant melanoma.

Sci Rep

July 2024

Department of Molecular Biology and Genomics, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin (JFM CU), Martin, Slovakia.

Article Synopsis
  • Malignant melanoma (MM) has numerous genetic changes and a quick spread, making it important to find new plasma biomarkers for easier diagnosis and monitoring.
  • The study investigated copy number variations (CNVs) in CDK genes and other specific genes through various genetic analyses, but found that CDK genes were not significant as biomarkers in plasma samples of MM patients compared to healthy individuals.
  • Despite the lack of significance for CDK genes, the analysis did identify common CNV regions in the genome, suggesting that the gene DIP2C could be promising for further research in liquid biopsy applications.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!